This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

Continue
Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
New eMC coming June 2013...

Astellas Pharma Ltd
2000 Hillswood Drive, Chertsey, Surrey, KT16 0RS, UK
Telephone: +44 (0) 203 379 8700
Fax: +44 (0) 203 379 8820
Medical Information Direct Line: 0800 783 5018
Medical Information e-mail: medinfo.gb@astellas.com
Stock Availability: +44 (0) 203 379 8721

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 01/03/2013
PIL Modigraf 0.2mg & 1mg granules for oral suspension

Following a review by the Commission on Human Medicines (CHM), updated advice on the prescribing and dispensing of oral tacrolimus products has been agreed. This updated advice is that all oral tacrolimus medicines in the UK should be prescribed and dispensed by brand name only.

Further information:

MHRA press release

Letter sent to healthcare professionals

Questions and answers document


The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged. This PIL is in PDF format.

View Patient Information Leaflet (0.142MB)

Are you having problems reading or printing this PDF? Visit adobe.com and download the Adobe Acrobat Reader.


More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/22721/PIL/


Active Ingredients/Generics